These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
228 related articles for article (PubMed ID: 33981772)
1. Circular RNA circPVT1 Contributes to Doxorubicin (DXR) Resistance of Osteosarcoma Cells by Regulating TRIAP1 via miR-137. Li D; Huang Y; Wang G Biomed Res Int; 2021; 2021():7463867. PubMed ID: 33981772 [TBL] [Abstract][Full Text] [Related]
2. Down-regulation of circITCH promotes osteosarcoma development and resistance to doxorubicin via the miR-524/RASSF6 axis. Zhou W; Liu Y; Wu X J Gene Med; 2021 Oct; 23(10):e3373. PubMed ID: 34151476 [TBL] [Abstract][Full Text] [Related]
3. miR-1301/TRIAP1 Axis Participates in Epirubicin-Mediated Anti-Proliferation and Pro-Apoptosis in Osteosarcoma. Yu L; Meng M; Bao Y; Zhang C; Gao B; Sa R; Luo W Yonsei Med J; 2019 Sep; 60(9):832-841. PubMed ID: 31433581 [TBL] [Abstract][Full Text] [Related]
4. CircRNA PVT1 promotes proliferation and chemoresistance of osteosarcoma cells via the miR-24-3p/KLF8 axis. Wang B; Yan L; Shi W; Xie H; Chen R; Shao Y; Liang W Int J Clin Oncol; 2022 Apr; 27(4):811-822. PubMed ID: 35171359 [TBL] [Abstract][Full Text] [Related]
5. Hsa_circ_0004674 promotes osteosarcoma doxorubicin resistance by regulating the miR-342-3p/FBN1 axis. Bai Y; Li Y; Bai J; Zhang Y J Orthop Surg Res; 2021 Aug; 16(1):510. PubMed ID: 34407841 [TBL] [Abstract][Full Text] [Related]
6. TFAP2C-mediated LINC00922 signaling underpins doxorubicin-resistant osteosarcoma. Gu Z; Zhou Y; Cao C; Wang X; Wu L; Ye Z Biomed Pharmacother; 2020 Sep; 129():110363. PubMed ID: 32563982 [TBL] [Abstract][Full Text] [Related]
7. Knockdown of cir_RNA PVT1 Elevates Gastric Cancer Cisplatin Sensitivity via Sponging miR-152-3p. Wang X; Zhang Y; Li W; Liu X J Surg Res; 2021 May; 261():185-195. PubMed ID: 33444948 [TBL] [Abstract][Full Text] [Related]
8. circ_0002060 Enhances Doxorubicin Resistance in Osteosarcoma by Regulating the miR-198/ABCB1 Axis. Ji Y; Liu J; Zhu W; Ji J Cancer Biother Radiopharm; 2023 Nov; 38(9):585-595. PubMed ID: 33351694 [No Abstract] [Full Text] [Related]
9. Tanshinone I restrains osteosarcoma progression by regulating circ_0000376/miR-432-5p/BCL2 axis. Ye B; Qiao K; Zhao Q; Jiang Z; Hu N; Wang F Mol Cell Biochem; 2022 Jan; 477(1):1-13. PubMed ID: 34532813 [TBL] [Abstract][Full Text] [Related]
10. Circular RNA_ANKIB1 accelerates chemo-resistance of osteosarcoma via binding microRNA-26b-5p and modulating enhancer of zeste homolog 2. Tang J; Duan G; Wang Y; Wang B; Li W; Zhu Z Bioengineered; 2022 Mar; 13(3):7351-7366. PubMed ID: 35264070 [TBL] [Abstract][Full Text] [Related]
11. LncRNA NORAD accelerates the progression and doxorubicin resistance of neuroblastoma through up-regulating HDAC8 via sponging miR-144-3p. Wang B; Xu L; Zhang J; Cheng X; Xu Q; Wang J; Mao F Biomed Pharmacother; 2020 Sep; 129():110268. PubMed ID: 32563146 [TBL] [Abstract][Full Text] [Related]
12. CircPRDM2 Contributes to Doxorubicin Resistance of Osteosarcoma by Elevating EZH2 via Sponging miR-760. Yuan J; Liu Y; Zhang Q; Ren Z; Li G; Tian R Cancer Manag Res; 2021; 13():4433-4445. PubMed ID: 34103997 [TBL] [Abstract][Full Text] [Related]
13. LncRNA LINC00152 Increases the Aggressiveness of Human Retinoblastoma and Enhances Carboplatin and Adriamycin Resistance by Regulating MiR-613/Yes-Associated Protein 1 (YAP1) Axis. Wang Y; Xin D; Zhou L Med Sci Monit; 2020 Jun; 26():e920886. PubMed ID: 32541644 [TBL] [Abstract][Full Text] [Related]
14. Long noncoding RNA OIP5-AS1 mediates resistance to doxorubicin by regulating miR-137-3p/PTN axis in osteosarcoma. Sun X; Tian C; Zhang H; Han K; Zhou M; Gan Z; Zhu H; Min D Biomed Pharmacother; 2020 Aug; 128():110201. PubMed ID: 32460190 [TBL] [Abstract][Full Text] [Related]
15. LncRNA Sox2OT-V7 promotes doxorubicin-induced autophagy and chemoresistance in osteosarcoma via tumor-suppressive miR-142/miR-22. Zhu K; Yuan Y; Wen J; Chen D; Zhu W; Ouyang Z; Wang W Aging (Albany NY); 2020 Apr; 12(8):6644-6666. PubMed ID: 32302291 [TBL] [Abstract][Full Text] [Related]
16. Circular RNA PVT1 silencing prevents ischemia-reperfusion injury in rat by targeting microRNA-125b and microRNA-200a. Luo C; Ling GX; Lei BF; Feng X; Xie XY; Fang C; Li YG; Cai XW; Zheng BS J Mol Cell Cardiol; 2021 Oct; 159():80-90. PubMed ID: 34097926 [TBL] [Abstract][Full Text] [Related]
17. CircPVT1 contributes to chemotherapy resistance of lung adenocarcinoma through miR-145-5p/ABCC1 axis. Zheng F; Xu R Biomed Pharmacother; 2020 Apr; 124():109828. PubMed ID: 31986409 [TBL] [Abstract][Full Text] [Related]
18. Circular RNA circ_0003028 contributes to tumorigenesis by regulating GOT2 via miR-1298-5p in non-small cell lung cancer. Guan H; Sun C; Gu Y; Li J; Ji J; Zhu Y Bioengineered; 2021 Dec; 12(1):2326-2340. PubMed ID: 34077306 [TBL] [Abstract][Full Text] [Related]
19. CircSAMD4A contributes to cell doxorubicin resistance in osteosarcoma by regulating the miR-218-5p/KLF8 axis. Wei W; Ji L; Duan W; Zhu J Open Life Sci; 2020; 15(1):848-859. PubMed ID: 33817271 [TBL] [Abstract][Full Text] [Related]
20. Linc00518 Contributes to Multidrug Resistance Through Regulating the MiR-199a/MRP1 Axis in Breast Cancer. Chang L; Hu Z; Zhou Z; Zhang H Cell Physiol Biochem; 2018; 48(1):16-28. PubMed ID: 30001527 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]